Accord Healthcare, Inc. is recalling 54,432 bottles of Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) because testing found the medication's potency fell below approved levels over time. Levothyroxine Sodium is a prescription drug used to treat an underactive thyroid (hypothyroidism). This recall affects 90-count bottles nationwide that were manufactured for Accord Healthcare by Intas Pharmaceuticals Limited.
The medication is subpotent, meaning it may not provide the full prescribed dose of the hormone. This could lead to a recurrence of hypothyroidism symptoms, such as fatigue, weight gain, and cold intolerance, because the patient is not receiving the expected therapeutic level of the drug.
You have 2 options:
Manufactured for Accord Healthcare, Inc. by Intas Pharmaceuticals Limited.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.